Blood test could Fine-Tune breast cancer therapy

NCT ID NCT06666439

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores whether a liquid biopsy (a blood test that detects tumor DNA) can help doctors adjust treatment early for people with metastatic lobular breast cancer. About 20 participants will have their blood tested regularly while on standard hormone therapy. The goal is to see if changes in tumor DNA levels can signal whether the treatment is working or needs to be changed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC INVASIVE LOBULAR CARCINOMA (MILC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Carcinoma, Lobular invasive lobular breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Magee Women's Hospital of UPMC

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••